OSE Immunotherapeutics (OSE) EUR0.2
Sell:€5.80Buy:€5.87
€0.20
(3.57%)
- This stock can be held in a
Stocks and Shares ISA€0.20
(3.57%)€0.20
(3.57%)Company Information
About this company
OSE Immunotherapeutics SA, formerly Orphan Synergy Europe Pharma SA, is a France-based company, engaged in clinical stage biotechnological sector. It develops immunotherapies, directly or through partnerships, for the activation and regulation of the immune system in immuno-oncology and in autoimmune diseases. The Company's research and development in immunology is based on 3 platforms, such as T cell-based vaccines, Immuno-Oncology (myeloid targets) and Auto-Immunity & Inflammation. It provides technological and scientific platforms: neoepitopes, agonist or antagonist monoclonal antibodies, ideally positioned to fight cancer and autoimmune diseases.
Key people
Key facts
- EPICOSE
- LocationFrance
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINFR0012127173
- Market cap€123.07m
- Employees52
- Shares in issue21.90m
- ExchangeEuronext Paris
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.